IR Delivers Deeper Webex Visibility with Support for Dedicated Instance.

2025-03-19 IDOPRESS

ORLANDO,Fla.,March 19,2025 --Integrated Research (IR) (ASX: IRI) today announced at Enterprise Connect a significant enhancement to its Webex monitoring capabilities: support for Webex Calling Dedicated Instance.

This update solidifies IR as the most feature-rich independent Webex monitoring solution,providing comprehensive visibility across Webex Calling,Webex Meetings,and now Webex Calling Dedicated Instance.

Webex Calling Dedicated Instance is a private cloud deployment of Webex Calling,offering enterprises a secure,dedicated UC environment with full control over configuration,integration,and scalability—while benefiting from the resilience and flexibility of the cloud.

However,managing these environments effectively requires deep visibility to prevent disruptions and optimize performance.

IR's latest enhancement eliminates blind spots,enabling IT teams to proactively monitor,troubleshoot,and optimize UC performance with confidence. With greater control and real-time insights,enterprises can ensure a seamless Webex experience across their entire collaboration ecosystem.

"Organizations adopting Webex Calling Dedicated Instance need confidence in their UC&C performance," said Ian Lowe,CEO of IR. "This enhancement makes IR's Webex offering the most advanced independent monitoring solution,providing unmatched visibility and control over enterprise UC environments."

Experience the future of Webex monitoring firsthand at Enterprise Connect—visit IR at booth #1200 for an exclusive live demo of our Webex Calling Dedicated Instance solution.

The new feature will be available at the end of March 2025.

About Integrated Research (IR)

Integrated Research (IR) (ASX:IRI) is the leading global provider of performance management solutions for critical IT infrastructure,payments and communications ecosystems. IR provides deep visibility into data,uncovering intelligent insight that helps organizations optimize the performance of business-critical systems and deliver exceptional technology experiences.

Since founding in 1988,IR has been committed to innovation,finding smarter ways to solve problems and power discovery to fuel the future.

Visit www.ir.com to find out more.

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

2The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

6MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM

MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM

©copyright 2009-2020 Singapore Info Map